Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-09-059804
Filing Date
2009-10-21
Accepted
2009-10-21 16:52:48
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a09-31868_1s3.htm S-3 493267
2 EX-5.1 a09-31868_1ex5d1.htm EX-5.1 10004
3 EX-23.1 a09-31868_1ex23d1.htm EX-23.1 3123
4 EX-23.2 a09-31868_1ex23d2.htm EX-23.2 3522
5 EX-23.3 a09-31868_1ex23d3.htm EX-23.3 2615
  Complete submission text file 0001104659-09-059804.txt   514086
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-162613 | Film No.: 091130506
SIC: 2835 In Vitro & In Vivo Diagnostic Substances